Lipid metabolism and coagulation during the normal menstrual cycle

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Lipid metabolism and coagulation during the normal menstrual cycle. / Lebech, A. M.; Kjaer, A.

In: Hormone and Metabolic Research, Vol. 21, No. 8, 1989, p. 445-448.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Lebech, AM & Kjaer, A 1989, 'Lipid metabolism and coagulation during the normal menstrual cycle', Hormone and Metabolic Research, vol. 21, no. 8, pp. 445-448. https://doi.org/10.1055/s-2007-1009258

APA

Lebech, A. M., & Kjaer, A. (1989). Lipid metabolism and coagulation during the normal menstrual cycle. Hormone and Metabolic Research, 21(8), 445-448. https://doi.org/10.1055/s-2007-1009258

Vancouver

Lebech AM, Kjaer A. Lipid metabolism and coagulation during the normal menstrual cycle. Hormone and Metabolic Research. 1989;21(8):445-448. https://doi.org/10.1055/s-2007-1009258

Author

Lebech, A. M. ; Kjaer, A. / Lipid metabolism and coagulation during the normal menstrual cycle. In: Hormone and Metabolic Research. 1989 ; Vol. 21, No. 8. pp. 445-448.

Bibtex

@article{7661badff7fe4630b7ab4df229a9ab74,
title = "Lipid metabolism and coagulation during the normal menstrual cycle",
abstract = "To examine the effects of sex-hormones on lipids, lipoproteins and coagulation in the normal menstrual cycle 37 women had blood samples taken early in the follicular phase (low estrogen) at the midcycle (high estrogen) and late in the luteal phase (high estrogen and high progesterone) under the best possible uniform and basal conditions. No significant changes (P > 0.05) in lipids and lipoproteins (including the HDL subfractions and apolipoproteins) were found throughout the menstrual cycle. In the coagulation system antithrombin III and factor VII did not change (P > 0.05). Fibrinogen, however, showed a significant (P < 0.05) increase in the luteal phase compared to the follicular phase and midcycle. Fibrinogen showed a significant positive correlation (r = 0.2766; P < 0.01) with progesterone, so the rise in fibrinogen in the luteal phase could be a progesterone effect. This longitudinal study performed on a large number of women under basal conditions showed that it seems of minor importance to define exact days of the cycle for analysing lipids and lipoproteins e. g. as controls in a study of lipid metabolism in women taking sex-hormones. For coagulation studies the cycle days may, however, be of importance.",
author = "Lebech, {A. M.} and A. Kjaer",
year = "1989",
doi = "10.1055/s-2007-1009258",
language = "English",
volume = "21",
pages = "445--448",
journal = "Hormone and Metabolic Research. Supplement",
issn = "0170-5903",
publisher = "GeorgThieme Verlag",
number = "8",

}

RIS

TY - JOUR

T1 - Lipid metabolism and coagulation during the normal menstrual cycle

AU - Lebech, A. M.

AU - Kjaer, A.

PY - 1989

Y1 - 1989

N2 - To examine the effects of sex-hormones on lipids, lipoproteins and coagulation in the normal menstrual cycle 37 women had blood samples taken early in the follicular phase (low estrogen) at the midcycle (high estrogen) and late in the luteal phase (high estrogen and high progesterone) under the best possible uniform and basal conditions. No significant changes (P > 0.05) in lipids and lipoproteins (including the HDL subfractions and apolipoproteins) were found throughout the menstrual cycle. In the coagulation system antithrombin III and factor VII did not change (P > 0.05). Fibrinogen, however, showed a significant (P < 0.05) increase in the luteal phase compared to the follicular phase and midcycle. Fibrinogen showed a significant positive correlation (r = 0.2766; P < 0.01) with progesterone, so the rise in fibrinogen in the luteal phase could be a progesterone effect. This longitudinal study performed on a large number of women under basal conditions showed that it seems of minor importance to define exact days of the cycle for analysing lipids and lipoproteins e. g. as controls in a study of lipid metabolism in women taking sex-hormones. For coagulation studies the cycle days may, however, be of importance.

AB - To examine the effects of sex-hormones on lipids, lipoproteins and coagulation in the normal menstrual cycle 37 women had blood samples taken early in the follicular phase (low estrogen) at the midcycle (high estrogen) and late in the luteal phase (high estrogen and high progesterone) under the best possible uniform and basal conditions. No significant changes (P > 0.05) in lipids and lipoproteins (including the HDL subfractions and apolipoproteins) were found throughout the menstrual cycle. In the coagulation system antithrombin III and factor VII did not change (P > 0.05). Fibrinogen, however, showed a significant (P < 0.05) increase in the luteal phase compared to the follicular phase and midcycle. Fibrinogen showed a significant positive correlation (r = 0.2766; P < 0.01) with progesterone, so the rise in fibrinogen in the luteal phase could be a progesterone effect. This longitudinal study performed on a large number of women under basal conditions showed that it seems of minor importance to define exact days of the cycle for analysing lipids and lipoproteins e. g. as controls in a study of lipid metabolism in women taking sex-hormones. For coagulation studies the cycle days may, however, be of importance.

UR - http://www.scopus.com/inward/record.url?scp=0024312887&partnerID=8YFLogxK

U2 - 10.1055/s-2007-1009258

DO - 10.1055/s-2007-1009258

M3 - Journal article

C2 - 2507434

AN - SCOPUS:0024312887

VL - 21

SP - 445

EP - 448

JO - Hormone and Metabolic Research. Supplement

JF - Hormone and Metabolic Research. Supplement

SN - 0170-5903

IS - 8

ER -

ID: 283517941